OPTIMAL DRUGS FOR MEDICATION REDUCTION: SECONDARY ANALYSIS OF THE OPTIMISE MEDICATION REDUCTION TRIAL

Sheppard J, Lown M, Burt J, Temple E, Ford G, Hobbs R, Little P, Mant J, Payne R, McManus R
No abstract available
Keywords:

32 Biomedical and Clinical Sciences

,

3201 Cardiovascular Medicine and Haematology

,

3202 Clinical Sciences

,

Prevention

,

Heart Disease

,

Aging

,

Patient Safety

,

Clinical Research

,

Women's Health

,

Clinical Trials and Supportive Activities

,

Cardiovascular

,

Hypertension

,

6.1 Pharmaceuticals

,

Cardiovascular